Literature DB >> 17537289

The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people.

Simone J P M Eussen1, Per M Ueland, Robert Clarke, Henk J Blom, Willibrord H L Hoefnagels, Wija A van Staveren, Lisette C P G M de Groot.   

Abstract

The importance of the one-carbon metabolites, choline and homocysteine, to brain function is well known. However, the associations between the one-carbon metabolites choline, betaine, methionine and dimethylglycine with cognition in elderly are unclear. We therefore examined the associations of these metabolites with cognition in a double-blind, placebo-controlled trial. Individuals (n 195) were randomized to receive daily oral capsules with either 1000 microg cobalamin (vitamin B12), or 1000 microg cobalamin plus 400 microg folic acid, or placebo for 24 weeks. Concentrations of homocysteine, methionine, choline, betaine and dimethylglycine were assessed before and after 12 and 24 weeks of treatment. Cognitive function, including domains of attention, construction, sensomotor speed, memory and executive function, was assessed before and after 24 weeks of treatment. At baseline, elevated plasma homocysteine was associated with lower performance of attention, construction, sensomotor speed and executive function. In addition, betaine was positively associated with better performance of construction, sensomotor speed and executive function, whereas elevated concentrations of methionine were positively associated with sensomotor speed. Daily combined supplementation with cobalamin plus folic acid decreased total homocysteine concentrations by 36%, and increased betaine concentrations by 38%. Participants with the largest increases in betaine concentrations showed a borderline significant (P = 0.07) higher memory performance compared to those without it. Although this trial observed associations of homocysteine and betaine with cognitive domains prior to supplementation, decreased concentrations of homocysteine were not related to improved cognitive performance. There was a tendency of participants with the largest increases in betaine concentrations to show the greatest improvement in memory function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537289     DOI: 10.1017/S0007114507750912

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  11 in total

1.  Betaine in the Brain: Characterization of Betaine Uptake, its Influence on Other Osmolytes and its Potential Role in Neuroprotection from Osmotic Stress.

Authors:  Leena S Knight; Quinn Piibe; Ian Lambie; Christopher Perkins; Paul H Yancey
Journal:  Neurochem Res       Date:  2017-09-16       Impact factor: 3.996

2.  Choline status and neurodevelopmental outcomes at 5 years of age in the Seychelles Child Development Nutrition Study.

Authors:  J J Strain; Emeir M McSorley; Edwin van Wijngaarden; Roni W Kobrosly; Maxine P Bonham; Maria S Mulhern; Alison J McAfee; Philip W Davidson; Conrad F Shamlaye; Juliette Henderson; Gene E Watson; Sally W Thurston; Julie M W Wallace; Per M Ueland; Gary J Myers
Journal:  Br J Nutr       Date:  2013-01-09       Impact factor: 3.718

3.  Folic acid attenuates cognitive dysfunction in streptozotocin-induced diabetic rats.

Authors:  Rui Yang; Rong-Ping Chen; Hong Chen; Hua Zhang; De-Hong Cai
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults.

Authors:  Annie J Roe; Shucha Zhang; Rafeeque A Bhadelia; Elizabeth J Johnson; Alice H Lichtenstein; Gail T Rogers; Irwin H Rosenberg; Caren E Smith; Steven H Zeisel; Tammy M Scott
Journal:  Am J Clin Nutr       Date:  2017-03-29       Impact factor: 7.045

5.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

6.  Choline intake and risk of lethal prostate cancer: incidence and survival.

Authors:  Erin L Richman; Stacey A Kenfield; Meir J Stampfer; Edward L Giovannucci; Steven H Zeisel; Walter C Willett; June M Chan
Journal:  Am J Clin Nutr       Date:  2012-09-05       Impact factor: 7.045

7.  Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.

Authors:  Anne Ws Rutjes; David A Denton; Marcello Di Nisio; Lee-Yee Chong; Rajesh P Abraham; Aalya S Al-Assaf; John L Anderson; Muzaffar A Malik; Robin Wm Vernooij; Gabriel Martínez; Naji Tabet; Jenny McCleery
Journal:  Cochrane Database Syst Rev       Date:  2018-12-17

8.  Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy.

Authors:  Jose M Colomina; Pere Cavallé-Busquets; Sílvia Fernàndez-Roig; Pol Solé-Navais; Joan D Fernandez-Ballart; Mónica Ballesteros; Per M Ueland; Klaus Meyer; Michelle M Murphy
Journal:  Nutrients       Date:  2016-10-09       Impact factor: 5.717

9.  Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.

Authors:  Jenny McCleery; Rajesh P Abraham; David A Denton; Anne Ws Rutjes; Lee-Yee Chong; Aalya S Al-Assaf; Daniel J Griffith; Shireen Rafeeq; Hakan Yaman; Muzaffar A Malik; Marcello Di Nisio; Gabriel Martínez; Robin Wm Vernooij; Naji Tabet
Journal:  Cochrane Database Syst Rev       Date:  2018-11-01

10.  Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain.

Authors:  Seyed Khosrow Tayebati; Ilenia Martinelli; Michele Moruzzi; Francesco Amenta; Daniele Tomassoni
Journal:  Nutrients       Date:  2017-09-29       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.